Fullerton, CANCT07225504Now EnrollingIRB Ready

Secondary Progressive Multiple Sclerosis (SPMS) Clinical Trial in Fullerton, CA

Access cutting-edge secondary progressive multiple sclerosis (spms) treatment through this clinical trial at a research site in Fullerton. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Fullerton location

Preparing your pre-screening questions…

Expert Care in Fullerton

Access secondary progressive multiple sclerosis (spms) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related secondary progressive multiple sclerosis (spms) treatment provided free

Apply for This Fullerton Location

Check if you qualify for this secondary progressive multiple sclerosis (spms) clinical trial in Fullerton, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fullerton

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fullerton site if eligible
  4. 4Begin participation

About This Secondary Progressive Multiple Sclerosis (SPMS) Study in Fullerton

The purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis (SPMS)

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Signed informed consent must be obtained prior to any assessment performed.
Male or female participants aged 18-65 (inclusive) at Screening.
Diagnosis of SPMS according to the 2017 revised McDonald criteria (Thompson et al 2018) at Screening.
Absence of documented clinical relapses in the 24 months before Screening and randomization.
EDSS score of 3.0 to 6.0 (inclusive) at Screening.
Documented evidence of disability progression in the 12 months before Screening.

Exclusion Criteria

Unwilling or unable to undergo MRI scans as per protocol (for example, claustrophobia, or presents absolute contraindications to MRI (e.g., metallic implants, metallic foreign bodies, pacemaker, defibrillator)).
History of clinically significant central nervous system (CNS) disease (e.g. stroke, traumatic brain or spinal injury, history or presence of myelopathy) or neurological disorders which may mimic multiple sclerosis (MS).
Ongoing substance abuse (drug or alcohol) or any other factor (e.g. serious psychiatric condition) that may interfere with the participant's ability to cooperate and comply with the study procedures.
Participants with history of confirmed Progressive Multifocal Leukoencephalopathy (PML) or neurological symptoms consistent with PML.
Women of childbearing potential (WOCBP), defined as all women physiologically capable of becoming pregnant from menarche until becoming post-menopausal, unless they are using highly effective methods of contraception (failure rate \< 1% per year) while taking study treatment and for at least 1 week after stopping study treatment.
Significant bleeding risk or coagulation disorders, at Screening.
Use of exclusionary medication prior to Screening/randomization as listed in the protocol. Other protocol-defined inclusion/exclusion critria may apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fullerton?

Yes, this clinical trial (NCT07225504) has an active research site in Fullerton, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Secondary Progressive Multiple Sclerosis (SPMS) Treatment Options in Fullerton, CA

If you're searching for secondary progressive multiple sclerosis (spms) treatment options in Fullerton, CA, this clinical trial (NCT07225504) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fullerton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced secondary progressive multiple sclerosis (spms) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all secondary progressive multiple sclerosis (spms) clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Fullerton, CA

See all multiple sclerosis clinical trials recruiting in Fullerton — not just this study.

Browse Multiple Sclerosis Trials in Fullerton →

Browse More Trials by Condition

Multiple Sclerosis TrialsAll Conditions →

Ready to Join in Fullerton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fullerton, CA